D.E. Shaw & Co
ARA

D.E. Shaw & Co’s American Renal Associates Holdings, Inc ARA Stock Holding History

D.E. Shaw & Co’s Portfolio ARA Stock Details ARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-46,941
Closed -$537K – 4686
2020
Q4 		$537K Sell
46,941
-30,724
-40% -$350K ﹤0.01% 3356
2020
Q3 		$536K Sell
77,665
-29,191
-27% -$192K ﹤0.01% 3196
2020
Q2 		$697K Buy
106,856
+16,899
+19% +$109K ﹤0.01% 3156
2020
Q1 		$595K Buy
89,957
+3,928
+5% +$34.2K ﹤0.01% 3114
2019
Q4 		$892K Sell
86,029
-1,125
-1% -$9.62K ﹤0.01% 3065
2019
Q3 		$551K Buy
+87,154
New +$650K ﹤0.01% 3171

D.E. Shaw & Co's ARA Position: Q1 2021 in Review

D.E. Shaw & Co sold out of American Renal Associates Holdings, Inc (ARA) in Q1 2021, closing a stake of 46,941 shares — an estimated $537K sold.

D.E. Shaw & Co first reported a position in ARA in Q3 2019 and held it in 6 quarters. The position peaked at $892K in Q4 2019. 0 funds tracked by Wall St. Rank hold ARA as of Q1 2021.

  • D.E. Shaw & Co reported no remaining American Renal Associates Holdings, Inc position as of Q1 2021 after selling out during the quarter.
  • D.E. Shaw & Co sold 46,941 American Renal Associates Holdings, Inc shares in Q1 2021, an estimated $537K.
  • D.E. Shaw & Co first reported a position in American Renal Associates Holdings, Inc in Q3 2019 and held it in 6 quarters.
  • D.E. Shaw & Co's American Renal Associates Holdings, Inc position peaked at $892K in Q4 2019.
  • 0 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q1 2021.

Based on D.E. Shaw & Co's 13F filing for Q1 2021, filed 17 May 2021.